Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study.

Brown JR, Solomon RJ, Robey RB, Plomondon ME, Maddox TM, Marshall EJ, Nichols EL, Matheny ME, Tsai TT, Rumsfeld JS, Lee RE, Sarnak MJ.

J Am Heart Assoc. 2016 Oct 14;5(10). pii: e003812.

2.

Meta-Analysis of Individual Patient Data of Sodium Bicarbonate and Sodium Chloride for All-Cause Mortality After Coronary Angiography.

Brown JR, Pearlman DM, Marshall EJ, Alam SS, MacKenzie TA, Recio-Mayoral A, Gomes VO, Kim B, Jensen LO, Mueller C, Maioli M, Solomon RJ.

Am J Cardiol. 2016 Nov 15;118(10):1473-1479. doi: 10.1016/j.amjcard.2016.08.008.

PMID:
27642111
3.

Examination of Prepregnancy and Pregnancy Urinary Protein Levels in Healthy Nulliparous Women.

Phillips JK, McBride CA, Hale SA, Solomon RJ, Badger GJ, Bernstein IM.

Reprod Sci. 2016 Jul 26. pii: 1933719116657198. [Epub ahead of print]

PMID:
27460407
4.

Contrast Medium-Induced Acute Kidney Injury.

Sadat U, Usman A, Boyle JR, Hayes PD, Solomon RJ.

Cardiorenal Med. 2015 Jun;5(3):219-28. doi: 10.1159/000430770. Review.

5.

The effects of glucose-lowering therapies on diabetic kidney disease.

Agrawal V, Giri C, Solomon RJ.

Curr Diabetes Rev. 2015;11(3):191-200. Review.

PMID:
25824237
6.

Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention.

Brown JR, Solomon RJ, Sarnak MJ, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, Stender JL, Conley SM, Robb JF, Chaisson K, Boss R, Lambert P, Goldberg DJ, Lucier D, Fedele FA, Kellett MA, Horton S, Phillips WJ, Downs C, Wiseman A, MacKenzie TA, Malenka DJ; Northern New England Cardiovascular Disease Study Group..

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):693-700. doi: 10.1161/CIRCOUTCOMES.114.000903.

7.

Antioxidant therapy with N-acetylcysteine for contrast-induced acute kidney injury: a final nail in the coffin?

Solomon RJ.

Coron Artery Dis. 2014 Mar;25(2):94-5. doi: 10.1097/MCA.0000000000000076. No abstract available.

PMID:
24492457
8.

Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?

Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ.

Circ Cardiovasc Interv. 2010 Aug;3(4):346-50. doi: 10.1161/CIRCINTERVENTIONS.109.910638.

9.

Creatinine increases after intravenous contrast administration: incidence and impact.

Li J, Solomon RJ.

Invest Radiol. 2010 Aug;45(8):471-6. doi: 10.1097/RLI.0b013e3181dc3b67. Review.

PMID:
20498612
10.

Using evidence-based management in a medical practice.

Solomon RJ.

J Med Pract Manage. 2010 Jan-Feb;25(4):245-50.

PMID:
20222263
11.

Contrast-induced nephropathy morbidity and mortality following percutaneous coronary intervention.

Brown JR, Solomon RJ.

Am J Cardiol. 2009 Dec 15;104(12):1763. doi: 10.1016/j.amjcard.2009.08.639. No abstract available.

PMID:
19962490
12.

Contrast-induced nephropathy and long-term adverse events: cause and effect?

Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ.

Clin J Am Soc Nephrol. 2009 Jul;4(7):1162-9. doi: 10.2215/CJN.00550109.

13.

Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.

Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE; Investigators of the CARE Study..

Circulation. 2007 Jun 26;115(25):3189-96.

14.
15.

Physician leadership: a roadmap for health-system change.

Solomon RJ.

J Med Pract Manage. 2004 Jul-Aug;20(1):36-40.

PMID:
15500022
16.

Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis.

Aggarwal A, Whitaker DA, Rimmer JM, Solomon RJ, Gennari FJ, Sobel BE, Schneider DJ.

Nephrol Dial Transplant. 2004 Jun;19(6):1559-63.

17.

Medical practice employee selection: application of recent research findings.

Solomon RJ.

J Med Pract Manage. 2003 Jan-Feb;18(4):219-23.

PMID:
12661485
18.

Mode of activation of salt secretion by C-type natriuretic peptide in the shark rectal gland.

Silva P, Solomon RJ, Epstein FH.

Am J Physiol. 1999 Dec;277(6 Pt 2):R1725-32.

19.

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.

Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS.

Am J Kidney Dis. 1998 Apr;31(4):674-80.

PMID:
9531185
20.

Transport mechanisms that mediate the secretion of chloride by the rectal gland of Squalus acanthias.

Silva P, Solomon RJ, Epstein FH.

J Exp Zool. 1997 Dec 1;279(5):504-8. Review.

PMID:
9392873
Items per page

Supplemental Content

Loading ...
Support Center